Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MARA vs GSK✓SelectedUSD · GSKMARA vs GSK performance historyLatest closeAs of-2.92%11/13
Stock and ETF performance explorer

MARA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-94.2%
GSK return
+122.1%
Excess return
-216.3%
Maximum drawdown
-99.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.9%+0.5%-3.4%-3.1%
7D+10.1%+1.1%+8.9%+9.5%
30D-15.1%+6.3%-21.4%-17.7%
3M-24.1%+1.8%-25.9%-25.5%
6M-45.2%+1.7%-46.8%-46.8%
YTD-22.2%+6.5%-28.7%-27.1%
1Y-45.3%+9.5%-54.8%-49.5%
3Y-23.9%+65.3%-89.2%-47.8%
5Y-90.8%+43.7%-134.5%-93.1%
10Y-81.0%+104.1%-185.1%-88.3%
All-94.2%+122.1%-216.3%-96.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling